80 % of medicines not covered by price control order-Page 2-Times Of India
Are pharma MNCs good for Indian consumers_ - NO _ Business Line
Book review Impoverishing the Poor
Business Line Opinion Clinical trials, or clinical errors
Business Line Too much faith in private healthcare
Business Line A muddled view of clinical trials
Business Line A way to evade drug price control
Business Line Ban drugs but do not suspend
Business Line Classic case of misplaced
Business Line Dangers of FDI in pharma
Business Line Drug pricing a bitter pill to swallow
Business Line Drug, healthcare prices are a rip-off
Business Line Opinion_A European pill best avoided
Business Line Opinion _ Loopholes in pharma pricing policy
Business Line Pharma industry gets away lightly
Business Line Right prescription for pharma
Business Line Should generic versions of Bayer
Business Line When clinical trials become dangerous
Choosing health over profit-The Hindu-2
Contact Patents article
Critique of New Drug Price Contorl Regime Yojana-April 2014- Anant Phadke, S. Srinivasan
Dec 2012 FDI in pharma, the wrong prescription
Drug price tug of war_ people vs others _ Business Line
EPW A_Stinging_Indictment
EPW DPCO 2013 Leaky Bucket, June 2013
EPW HLEG Medicines for all epw feb 2012
EPW HPV EPE june 2011
EPW HPV Vaccine
EPW medicines for all, June 2011
EPW Natco CL
EPW NPPP 2011 critique Jan 2012
EPW Pharma Price Control Policy Aug 2014
EPW Pharma Patents after 10 Years
EPW Pharma Policy 2012 and Its Discontents
EPW Why Paswan's price reduction is a let down
Everything you need to know about essential drugs
FDA's letter to Wockhardt is fair-Livemint
Health Action Sep 2009 Issue
IJME A network for rational drugs
IJME Draft National pharma Policy, price control and data exclusivity Concerns
IJME How TRIPS benefits Indian Industry
IJME Revised Drugs that find market Chinu, IJME
IJME Serial Maternal deaths
IJME Spurious drug gene and its pervasiveness
IJME Trained quacks an Indian drug tragedy
Info change Disease Mongering
Live Mint - FDA's letter to Wockhardt is fair- August 2, 2013
Mala_Fide_Decision_on_Drug_Prices.pdf
Market Based Mechanism of Drug Price Regulation Unpublished
Medicines for all some positive initiatives
Negotiating FDCs (Unpublished)
NMJI India's Patent Laws and the Multinational Pharma Industry
'No patent protection for Glivec', Supreme Court -The American Bazaar
Pharma security
Pharma Patents after 10 Years
Prescribing generic drugs, Pharma Biz
Pricing of Patented Drugs
The Maggi Order
The need to cut pharma super-profits _ Analysis _ Public health
The Practice Of Unethics
Who decides how much my Crocin will cost
